Weekly CEO Buying Highlight – GuruFocus.com

According to GuruFocus Insider Data, these are the biggest CEO buys in the past week.

Instill the Bio

Instil Bio Inc. (UP TO, Financial), CEO, President and 10% owner, Bronson Crouch purchased 450,000 shares on March 23 at a price of $ 20.00. The share price has risen 35.3% since then.

Instil Bio, a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients. The company is developing tumor-infiltrating autologous lymphocyte cell therapy (UP TO, financial) to treat cancer patients. Its TIL product candidates under development include ITIL-168 for indications such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, squamous cell carcinoma of the head and neck, and cervical cancer. ‘uterus ; and ITIL-306 (FOLR1) with indications including gynecologic and other non-small cell lung cancer.

The company has a market capitalization of $ 3.40 billion. Its shares were trading at $ 27.06 as of March 26.

On March 23, 2021, the company announced the closing of its initial public offering of 18,400,000 common shares at a public offering price of $ 20.00 per share.

10% owner Vivo Capital Fund IX, LP purchased 300,000 shares on March 23 at a price of $ 20. Since then, the share price has risen 35.3%.

Director Nimish P. Shah bought 300,000 shares on March 23 at a price of $ 20. The share price has risen 35.3% since then.

Director Jack Nielsen bought 300,000 shares on March 23 at a price of $ 20. Since then, the share price has risen 35.3%.

Director R. Kent McGaughy Jr. bought 450,000 shares on March 23 at a price of $ 20. The share price has risen 35.3% since then.

10% owner Curative Ventures V LLC purchased 450,000 shares on March 23 for $ 20. Since then, the share price has risen 35.3%.

Advantage Solutions

Advantage Solutions Inc. (ADV, Financial), CEO Tanya L. Domier bought 27,250 shares on March 19 at a price of $ 11.07. The share price has risen 6.96% since then.

820b233951faa2d0647e0c13f4f8e614.png

Advantage Solutions is a leading provider of business solutions for manufacturers and retailers of consumer goods. Its customizable suite of technology-based sales and marketing solutions are designed to help manufacturers and retailers across a wide range of channels drive consumer demand, increase sales and achieve operational efficiency. The company offers headquarters relationship management services, analytics, insights and intelligence, retail services, experiential marketing and digital marketing, among others.

The company has a market capitalization of $ 3.77 billion. Its shares were trading at $ 11.84 as of March 26.

Net loss amounted to $ 138.9 million for the fourth quarter of 2020, compared to net income of $ 14.8 million for the fourth quarter of 2019.

North America CFO Dean Kaye bought 2,582 shares on March 23 for $ 11.56. Since then, the share price has risen 2.42%.

CFO and COO Brian Stevens bought 4,310 shares on March 23 for $ 11.61. The share price has since risen 1.98%.

President and Chief Commercial Officer Jill L. Griffin purchased 4,290 shares on March 23 for $ 11.63. The share price has risen 1.81% since then.

Director James M. Kilts purchased 64,463 shares on March 22 at a price of $ 10.89. The share price has since risen 8.72%.

Golub Capital BDC

Golub Capital BDC Inc. (GBDC, Financial) CEO David Golub bought 12,000 shares over the past week at an average price of $ 14.81.

2d5ee70a81fdffe8969912cbe0c2588a.png

Golub Capital BDC is an externally managed, non-diversified, closed-end investment management firm. The company’s investment objective is to generate current income and capital appreciation by investing in senior, one-stop secured loans in mid-market US companies. It also invests in second and subordinated loans, warrants and minority equity securities in mid-market companies.

The company has a market capitalization of $ 2.52 billion. Its shares were trading at $ 15.08 with a price-earnings ratio of 23.24 as of March 26.

For the first quarter of fiscal 2021, net investment income amounted to $ 39.0 million compared to $ 32.7 million for the comparable quarter of 2020.

CEO David Golub bought 4,000 shares on March 15 at a price of $ 14.85; 4,000 shares on March 17 at a price of $ 14.64; 4,000 shares on March 19 at a price of $ 14.7; 4,000 shares on March 23 at a price of $ 14.91; and 4,000 shares on March 25 priced at $ 14.82. The share price has risen 1.75% since then.

President Lawrence E. Golub bought 4,000 shares on March 15 at a price of $ 14.85; 4,000 shares on March 17 at a price of $ 14.64; 4,000 shares on March 19 at a price of $ 14.7; 4,000 shares on March 23 at a price of $ 14.91; and 4,000 shares on March 25 priced at $ 14.82. The share price has since risen 1.75%.

Adverum Biotechnologies

Adverum Biotechnologies Inc. (ADVM, Financial) CEO and Director Laurent Fischer bought 10,000 shares on March 24 at a price of $ 9.88. The share price has risen 0.61% since then.

ed145d052a5d7790ca4447af1259f780.png

Adverum Biotechnologies is an American clinical stage gene therapy company. The company is committed to discovering and developing new drugs that may offer life-changing therapeutic benefits for patients living with rare diseases or eye diseases, who currently have limited or burdensome treatment options. . Its services focus on advancing three leading gene therapy programs to address unmet needs in wet age-related macular degeneration and rare diseases, alpha-1 antitrypsin deficiency and angio – hereditary edema. Its main programs include ADVM-022, ADVM-043 and ADVM-053.

The company has a market capitalization of $ 972.09 million. Its shares were trading at $ 9.94 as of March 26.

The net loss amounted to $ 27.8 million for the quarter ended September 30, 2020, compared to $ 16.1 million for the same period in 2019.

Director Patrick Machado bought 10,000 shares on March 24 at a price of $ 9.92. Since then, the share price has risen 0.2%.

Maxar Technologies

Maxar Technologies Inc. (MAXR, Financial) President and CEO Daniel L. Jablonsky purchased 1,500 shares on March 25 at a price of $ 35.72. The share price has since risen 5.38%.

a5a898592bb37df05f0bbaf8f9ee4878.png

Maxar Technologies is an integrated spatial and geospatial intelligence company with a full suite of space technology solutions for commercial and government customers, including satellites, Earth imagery, geospatial data and analytics.

The company has a market capitalization of $ 2.7 billion. Its shares were trading at $ 37.64 with a price-earnings ratio of 7.54 as of March 26.

The net loss for the fourth quarter of 2020 was $ 52 million, compared to net income of $ 53 million for the same period in 2019.

For the full list of shares purchased by their company’s CEOs, please visit: CEO buys.

Disclosure: I do not own any shares in any of the companies mentioned in the article.

Not a GuruFocus Premium member? Sign up for a 7 day free trial here.

About Geraldine Higgins

Check Also

House passes bill easing restrictions on PPP loans: associations now

What is this? Associations now Brand Connection offers advertisers the ability to connect with the …

Leave a Reply

Your email address will not be published.